US drug shortages rise for third straight quarter, hurt by lone suppliers

US drug shortages rose for a third straight quarter to 227, per ASHP, with almost half having single manufacturers. Testicular cancer drug ifosfamide is one in short supply. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act…

Anna Brown · 2026-07-16

The number of drugs in shortage in the US rose for a third straight quarter, a situation complicated by the fact that almost half of the medicines in tight supply rely only on a single ...

Source: Endpoints News